JPS58406B2 - コウドジヤクドクカサイトメガロウイルスワクチント ソノセイホウ - Google Patents

コウドジヤクドクカサイトメガロウイルスワクチント ソノセイホウ

Info

Publication number
JPS58406B2
JPS58406B2 JP50044153A JP4415375A JPS58406B2 JP S58406 B2 JPS58406 B2 JP S58406B2 JP 50044153 A JP50044153 A JP 50044153A JP 4415375 A JP4415375 A JP 4415375A JP S58406 B2 JPS58406 B2 JP S58406B2
Authority
JP
Japan
Prior art keywords
virus
cmv
vaccine
cell
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP50044153A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5115612A (enExample
Inventor
スタンリー・エー・プロトキン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
The Wistar Institute
Original Assignee
The Wistar Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Wistar Institute filed Critical The Wistar Institute
Publication of JPS5115612A publication Critical patent/JPS5115612A/ja
Publication of JPS58406B2 publication Critical patent/JPS58406B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP50044153A 1974-04-15 1975-04-11 コウドジヤクドクカサイトメガロウイルスワクチント ソノセイホウ Expired JPS58406B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/460,951 US3959466A (en) 1974-04-15 1974-04-15 Highly attenuated cytomegalovirus vaccine and production thereof

Publications (2)

Publication Number Publication Date
JPS5115612A JPS5115612A (enExample) 1976-02-07
JPS58406B2 true JPS58406B2 (ja) 1983-01-06

Family

ID=23830680

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50044153A Expired JPS58406B2 (ja) 1974-04-15 1975-04-11 コウドジヤクドクカサイトメガロウイルスワクチント ソノセイホウ

Country Status (11)

Country Link
US (1) US3959466A (enExample)
JP (1) JPS58406B2 (enExample)
BE (1) BE827572A (enExample)
CA (1) CA1045546A (enExample)
CH (1) CH617588A5 (enExample)
DE (1) DE2516274C2 (enExample)
FR (1) FR2267117B1 (enExample)
GB (1) GB1501724A (enExample)
NL (1) NL7504480A (enExample)
SE (1) SE7504221L (enExample)
ZA (1) ZA751949B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058598A (en) * 1974-10-18 1977-11-15 Harold Stern Cytomegalovirus attenuation method and vaccine
AU532186B2 (en) * 1978-07-21 1983-09-22 Merck & Co., Inc. Herpes virus vaccine
US6242567B1 (en) 1984-07-27 2001-06-05 City Of Hope Method for detection and prevention of human cytomegalovirus infection
US6133433A (en) * 1984-07-27 2000-10-17 City Of Hope Method for detection and prevention of human cytomegalovirus infection
US5194256A (en) * 1984-08-21 1993-03-16 The Board Of Trustees Of The Leland Sanford Junior University Purified human cytomegalovirus protein
US4689225A (en) * 1984-11-02 1987-08-25 Institut Merieux Vaccine for cytomegalovirus
US5126130A (en) * 1986-11-24 1992-06-30 The Childrens Hospital Incorporated Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a
US5248768A (en) * 1986-11-24 1993-09-28 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus
US5153311A (en) * 1986-11-24 1992-10-06 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus gCII
EP0277773A1 (en) * 1987-01-30 1988-08-10 The Board Of Trustees Of The Leland Stanford Junior University Hybrid cytomegalovirus (CMV) and vaccine
US5591439A (en) * 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
US5552143A (en) * 1989-03-24 1996-09-03 The Wistar Institute Of Anatomy & Biology Recombinant cytomegalovirus vaccine
US5180813A (en) * 1989-03-24 1993-01-19 University Of Iowa Research Foundation Early envelope glycoprotein of human cytomegalovirus (hmcv) and monoclonal antibodies to the glycoproteins
US6448389B1 (en) 1996-04-23 2002-09-10 The Wistar Institute Of Anatomy And Biology Human cytomegalovirus DNA constructs and uses therefor
US6835383B2 (en) * 2000-03-23 2004-12-28 City Of Hope Protein kinase deficient, immunologically active CMVpp65 mutants
EP1178111A1 (en) * 2000-08-03 2002-02-06 Lohmann Animal Health GmbH & Co. KG Vaccination against host cell-associated herpesviruses
US6692954B1 (en) 2000-11-03 2004-02-17 The Scripps Research Institute Generation of human cytomegalovirus yeast artificial chromosome recombinants
US9439960B2 (en) 2007-10-10 2016-09-13 The Trustees Of Princeton University Cytomegalovirus vaccines and methods of production
WO2021014398A1 (en) 2019-07-23 2021-01-28 University Of Rijeka Faculty Of Medicine Integrated human cytomegalovirus / glioblastoma vaccine

Also Published As

Publication number Publication date
CH617588A5 (enExample) 1980-06-13
DE2516274C2 (de) 1986-10-30
FR2267117A1 (enExample) 1975-11-07
ZA751949B (en) 1976-02-25
SE7504221L (sv) 1975-12-22
NL7504480A (nl) 1975-10-17
BE827572A (fr) 1975-10-06
DE2516274A1 (de) 1975-10-23
JPS5115612A (enExample) 1976-02-07
CA1045546A (en) 1979-01-02
GB1501724A (en) 1978-02-22
FR2267117B1 (enExample) 1978-11-24
US3959466A (en) 1976-05-25
AU8002475A (en) 1976-10-14

Similar Documents

Publication Publication Date Title
Freer et al. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies
US3959466A (en) Highly attenuated cytomegalovirus vaccine and production thereof
KR100374295B1 (ko) 돼지생식및호흡증후군바이러스의생육방법과백신에서그의용도
Kaashoek et al. An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation
Bradburne et al. Coronavirus antibody titres in sera of healthy adults and experimentally infected volunteers
US4122167A (en) Respiratory synctial vaccine
Prinzie et al. Experimental live attenuated rubella virus vaccine: clinical evaluation of Cendehill strain
KR0171434B1 (ko) 인체 로타바이러스, 백신 및 방법
JPS6216933B2 (enExample)
le Q Darcel et al. Recovery of infectious bovine rhinotracheitis virus following corticosteroid treatment of vaccinated animals
Nahmias et al. 36 Experimental Genital Herpes Simplex infection in the Mouse
US4145252A (en) Respiratory syncytial vaccine
PLOTKIN et al. An attenuated rubella virus strain adapted to primary rabbit kidney
Dutta et al. Cell mediated immunity in equine herpesvirus type 1 infection I. In vitro lymphocyte blastogenesis and serum neutralization antibody in normal parturient and aborting mares
Du Pan et al. Attenuation of rubella virus by serial passage in primary rabbit kidney cells: III. Clinical trials in infants
US3660565A (en) Rubella vaccine and method
CN117180413B (zh) 柯萨奇病毒a组2型疫苗株在激发交叉免疫保护中的应用
US3544680A (en) Intranasal immunization against rubella
US20080089910A1 (en) Attenuated Herpes Simplex Virus Type-2, Vectors Thereof and Immunogenic Compositions Thereof
White et al. Inactivated eastern equine encephalomyelitis vaccines prepared in monolayer and concentrated suspension chick embryo cultures
KR0135614B1 (ko) 약독화 수두 생바이러스 백신 및 그의 제조방법
AU778157B2 (en) Equine herpes virus temperature sensitive mutant and live vaccine thereof
Van Oirschot et al. Early protection after vaccination against Aujeszky’s disease
JP2000516622A (ja) 交差防御的ウマヘルペスウイルス製剤並びにそれらの製造及び使用方法
SU439956A1 (ru) Способ получени штаммов вирусов дл стимул ции интерфероногенеза